BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES

被引:527
作者
BOEL, P
WILDMANN, C
SENSI, ML
BRASSEUR, R
RENAULD, JC
COULIE, P
BOON, T
VANDERBRUGGEN, P
机构
[1] UNIV CATHOLIQUE LOUVAIN,CELLULAR GENET UNIT,B-1200 BRUSSELS,BELGIUM
[2] IST NAZL STUDIO & CURA TUMORI,DIV EXPTL ONCOL D,I-20133 MILAN,ITALY
[3] FAC SCI AGRON ETAT GEMBLOUX,CTR BIOPHYS MOLEC NUMER,B-5030 GEMBLOUX,BELGIUM
关键词
D O I
10.1016/S1074-7613(95)80053-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several tumor antigens are recognized by autologous cytolytic T lymphocytes (CTL) on human melanoma MZ2-MEL. Some of them are encoded by genes MAGE-1 and MAGE-3, which are not expressed in normal tissues except in testis. Here, we report the identification of a new gene that codes for another of these antigens. This gene, named SAGE, codes for a putative protein of 43 aa and seems to belong to a family of several genes. The antigen recognized by the autologous CTL consists of BAGE-encoded peptide AARAVFLAL bound to an HLA-Cw*1601 molecule. Gene BAGE is expressed in 22% of melanomas, 30% of infiltrating bladder carcinomas, 10% of mammary carcinomas, 8% of head and neck squamous cell carcinomas, and 6% of non-small cell lung carcinomas. Like the MAGE genes, it is silent in normal tissues with the exception of testis. Because of its tumor-specific expression, the BAGE-encoded antigen may prove useful for cancer immunotherapy.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 37 条
[11]   SEQUENCE AND EXPRESSION PATTERN OF THE HUMAN MAGE2 GENE [J].
DESMET, C ;
LURQUIN, C ;
VANDERBRUGGEN, P ;
DEPLAEN, E ;
BRASSEUR, F ;
BOON, T .
IMMUNOGENETICS, 1994, 39 (02) :121-129
[12]  
ESPAVIK T, 1986, J IMMUNOL METHODS, V95, P99
[13]   HUMAN GENE MAGE-3 CODES FOR AN ANTIGEN RECOGNIZED ON A MELANOMA BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES [J].
GAUGLER, B ;
VANDENEYNDE, B ;
VANDERBRUGGEN, P ;
ROMERO, P ;
GAFORIO, JJ ;
DEPLAEN, E ;
LETHE, B ;
BRASSEUR, F ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :921-930
[14]   AN EXPERIMENTALLY VALIDATED PANEL OF SUBFAMILY-SPECIFIC OLIGONUCLEOTIDE PRIMERS (V-ALPHA-1-W29/V-BETA-1-W24) FOR THE STUDY OF HUMAN T-CELL RECEPTOR VARIABLE V-GENE SEGMENT USAGE BY POLYMERASE CHAIN-REACTION [J].
GENEVEE, C ;
DIU, A ;
NIERAT, J ;
CAIGNARD, A ;
DIETRICH, PY ;
FERRADINI, L ;
ROMANROMAN, S ;
TRIEBEL, F ;
HERCEND, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (05) :1261-1269
[15]  
HAAS GG, 1988, AM J REPROD IMMUNOL, V18, P47
[16]   RE-EXAMINATION AND FURTHER DEVELOPMENT OF A PRECISE AND RAPID DYE METHOD FOR MEASURING CELL-GROWTH CELL KILL [J].
HANSEN, MB ;
NIELSEN, SE ;
BERG, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 119 (02) :203-210
[17]   PRODUCTION OF STABLE CYTOLYTIC T-CELL CLONES DIRECTED AGAINST AUTOLOGOUS HUMAN-MELANOMA [J].
HERIN, M ;
LEMOINE, C ;
WEYNANTS, P ;
VESSIERE, F ;
VANPEL, A ;
KNUTH, A ;
DEVOS, R ;
BOON, T .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (03) :390-396
[18]   THEORETICAL AND FUNCTIONAL-ANALYSIS OF THE SIV FUSION PEPTIDE [J].
HORTH, M ;
LAMBRECHT, B ;
KHIM, MCL ;
BEX, F ;
THIRIART, C ;
RUYSSCHAERT, JM ;
BURNY, A ;
BRASSEUR, R .
EMBO JOURNAL, 1991, 10 (10) :2747-2755
[19]   CLONING OF THE GENE CODING FOR A SHARED HUMAN-MELANOMA ANTIGEN RECOGNIZED BY AUTOLOGOUS T-CELLS INFILTRATING INTO TUMOR [J].
KAWAKAMI, Y ;
ELIYAHU, S ;
DELGADO, CH ;
ROBBINS, PF ;
RIVOLTINI, L ;
TOPALIAN, SL ;
MIKI, T ;
ROSENBERG, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3515-3519
[20]  
Mostofi FK., 1973, HISTOLOGICAL TYPING